最新报道：Predictive Oncology Inc. (NASDAQ: POAI), a medical device company, announced today, September 29, that it has priced two private placements to support the implementation of its digital asset library strategy, with ATH, the native utility token of the Aethir ecosystem, as its core holding. The company will raise approximately $344.4 million through two Publicly Traded Private Investment in Profits (PIPEs) to fund the purchase and sale of common stock and pre-warrants. The following is a cash PIPE: The company will issue approximately 66.7 million shares of common stock (or pre-warrants in lieu of common stock) at a price of $0.7751 per share, generating approximately $51.7 million in gross cash proceeds. Crypto PIPE: The Company will issue up to 223.6 million pre-warrants at a price equal to the offering price less $0.01 each, in exchange for approximately $292.7 million in notional value, representing a discounted value of approximately $173.3 million, in the form of an in-kind contribution of locked and unlocked Aethir tokens. The pre-warrants in the Crypto PIPE will be exercisable immediately upon the Company's receipt of shareholder approval. Both PIPEs are expected to close simultaneously on or about October 2, 2025, subject to customary closing conditions. The Company intends to use the in-kind contribution of Aethir (ATH) to implement its digital asset library strategy and to use the remaining net proceeds from the PIPEs to primarily acquire ATHs in the open market to further support this strategy, as well as for working capital and general corporate purposes.